Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516-Reference-Cited by-同舟云学术

Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516

Published:2018-02 Issue:3 Volume:28 Page:533-536
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Lagu Bharat,Kluge Arthur F.,Goddeeris Matthew M.,Tozzo Effie,Fredenburg Ross A.,Chellur Shekar,Senaiar Ramesh S.,Jaleel Mahaboobi,Babu D. Ravi Krishna,Tiwari Nirbhay K.,Takahashi Taisuke,Patane Michael A.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference17 articles.

1. Rosiglitazone-Associated Fractures in Type 2 Diabetes

2. Examining the safety of PPAR agonists – current trends and future prospects

3. Effect of Muraglitazar on Death and Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus

4. PPAR : a dagger in the heart of the metabolic syndrome

5. Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of the therapeutic potential of PPARδ agonist bearing 1,3,4- thiadiazole in inflammatory disorders;European Journal of Medicinal Chemistry;2024-12

2. Organophosphorus-Catalyzed “Dual-Substrate Deoxygenation” Strategy for C–S Bond Formation from Sulfonyl Chlorides and Alcohols/Acids;The Journal of Organic Chemistry;2023-06-09

3. Peroxisome Proliferator-Activated Receptor Delta Agonist (PPAR- δ) and Selective Androgen Receptor Modulator (SARM) Abuse: Clinical, Analytical and Biological Data in a Case Involving a Poisonous Combination of GW1516 (Cardarine) and MK2866 (Ostarine);Toxics;2021-10-07

4. PPARα and δ Ligand Design: Honing the Traditional Empirical Method with a More Holistic Overview;Nuclear Receptors;2021

5. Targeting Peroxisome Proliferator-Activated Receptor Delta (PPARδ): A Medicinal Chemistry Perspective;Journal of Medicinal Chemistry;2020-06-15